The rating affirmation is based on a number of factors, including DCH Health System’s strong market position and affiliation with Houston-based MD Anderson Cancer Center.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that the health system will maintain a strong market share and preserve its operating margins.
More articles on healthcare finance:
Judge refuses to rescind order requiring HHS to clear Medicare appeals backlog
Palmetto Health swings into the black in FY 2016
New NC governor plans to take immidiate action on Medicaid expansion
